Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00032708
Status:
COMPLETED
Last Update Posted:
2010-08-27
First Post:
2002-03-28
Brief Title:
Dryvax Dilution-Prev Vacc Adults
Sponsor:
National Institute of Allergy and Infectious Diseases NIAID
Organization:
National Institute of Allergy and Infectious Diseases NIAID
Study Overview
Official Title:
A Double Blind Randomized Dose Response Study of Dryvax Vaccine Against Smallpox in Previously Vaccinated Adults
Status:
COMPLETED
Status Verified Date:
2006-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A double-blind randomized dose-response study of four dilutions of Dryvax in previously vaccinated adults in order to assess the clinical success rates humoral responses and virus-specific actifity of cytotoxi T cells and interferon-y producing T cells
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None